Bone healing requires a complex interaction of growth factors that establishes an environment for efficient bone regeneration. Among these, FGFs have been considered important for intrinsic bonehealing capacity. In this study, we analyzed the role of Fgf-9 in long bone repair. One-millimeter unicortical defects were created in tibias of Fgf-9 +/− and wild-type mice. Histomorphometry revealed that half-dose gene of Fgf-9 markedly reduced bone regeneration as compared with wild-type. Both immunohistochemistry and RT-PCR analysis revealed markedly decreased levels of proliferating cell nuclear antigen (PCNA), Runt-related transcription factor 2 (Runx2), osteocalcin, Vega-a, and platelet endothelial cell adhesion molecule 1 (PECAM-1) in Fgf-9 +/− defects. μCT angiography indicated dramatic impairment of neovascularization in Fgf-9 +/− mice as compared with controls. Treatment with FGF-9 protein promoted angiogenesis and successfully rescued the healing capacity of Fgf-9 +/− mice. Importantly, although other pro-osteogenic factors [Fgf-2, Fgf-18, and bone morphogenic protein 2 (Bmp-2)] still were present in Fgf-9 +/− mice, they could not compensate for the haploinsufficiency of the Fgf-9 gene. Therefore, endogenous Fgf-9 seems to play an important role in long bone repair. Taken together our data suggest a unique role for Fgf-9 in bone healing, presumably by initiating angiogenesis through Vegf-a. Moreover, this study further supports the embryonic phenotype previously observed in the developing limb, thus promoting the concept that healing processes in adult organisms may recapitulate embryonic skeletal development.tibia | regeneration | tissue B one healing is an efficient regenerative process resulting in newly formed bone equivalent to the original tissue. It involves the interplay of numerous factors over the well-characterized cascade of phases, including inflammation, callus formation, and remodeling (1), which recapitulate aspects of skeletal development (2, 3). Among these factors, several members of the FGF ligands, including FGF-2, -9, and -18, as well their corresponding receptors FGFR1-3, have been identified previously as having a major role during skeletal development (4-12). Although their contribution during skeletal development is well established, less is known about FGFs in fracture healing. The recent identification of different expression patterns of FGF ligands and receptors during fracture repair (13) indicates potential functions in bone regeneration. Within the group of pro-osteogenic FGF ligands, Fgf-9 has been reported to play a role during the development of skeletal vascularization (11).Skeletal vascularization of the injury site is a key step in facilitating successful bone regeneration. Angiogenesis is achieved by two hormonal pathways: the angiopoietin-and VEGF-mediated pathways (2, 14). Vegf was identified previously as a coordinator of chondrocyte growth and bone formation in growth plates of juvenile mice (15). Moreover, Vegf is released physiologically in fracture hematoma (16). C...